Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Short-term Investments (2020 - 2023)

IceCure Medical has reported Short-term Investments over the past 3 years, most recently at $529000.0 for Q4 2023.

  • For Q4 2023, Short-term Investments rose 78.72% year-over-year to $529000.0; the TTM value through Dec 2023 reached $529000.0, up 78.72%, while the annual FY2023 figure was $529000.0, 78.72% up from the prior year.
  • Short-term Investments was $529000.0 for Q4 2023 at IceCure Medical, up from $296000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $4.7 million in Q4 2020 and bottomed at $296000.0 in Q4 2022.
  • The 3-year median for Short-term Investments is $529000.0 (2023), against an average of $1.8 million.
  • The widest YoY moves for Short-term Investments: up 78.72% in 2023, down 78.72% in 2023.
  • Over 3 years, Short-term Investments stood at $4.7 million in 2020, then crashed by 93.66% to $296000.0 in 2022, then soared by 78.72% to $529000.0 in 2023.
  • The last three reported values for Short-term Investments were $529000.0 (Q4 2023), $296000.0 (Q4 2022), and $4.7 million (Q4 2020) per Business Quant data.